gene expression
Early ESMO Data Show Interferon Signature's Ability to Guide Neoadjuvant Melanoma Immunotherapy
In the Phase I DOMINI trial, patients received combinations of BMS' Opdivo, Yervoy, and 4SC's domatinostat based on their tumors' interferon gamma gene expression.
Through its real-world evidence registry, the firm hopes to further validate its NSCLC recurrence risk test as a tool for guiding adjuvant treatment.
Labcorp, CCORN Ink Partnership to Address Precision Oncology Disparities
The Community Clinical Oncology Research Network will leverage Labcorp's comprehensive genomic profiling test to build out a registry of diverse patient data.Â
FDA Accepts Allarity Therapeutics' PMA for Dovitinib Companion Test
The agency will now review Dovitinib-DRP's ability to select kidney cancer patients likely to respond to the repurposed TKI.
Overexpressed Cancer Testis Antigen Could Reflect Therapeutic Target in Liver Cancer
A new study has found that MAGEA3 is overexpressed in aggressive liver cancer and has a role in upregulating survivin to inhibit apoptosis.
Mar 18, 2021
Oct 21, 2020